Compare Henry Schein, Inc. with Similar Stocks
Dashboard
1
High Management Efficiency with a high ROCE of 15.35%
2
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 1.57 times
3
Poor long term growth as Operating profit has grown by an annual rate 6.07% of over the last 5 years
4
Flat results in Sep 25
5
With ROCE of 12.11%, it has a fair valuation with a 1.81 Enterprise value to Capital Employed
6
Rising Promoter Confidence
7
Underperformed the market in the last 1 year
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-6.14%
0%
-6.14%
6 Months
5.46%
0%
5.46%
1 Year
0.4%
0%
0.4%
2 Years
-2.55%
0%
-2.55%
3 Years
-6.44%
0%
-6.44%
4 Years
-17.16%
0%
-17.16%
5 Years
6.8%
0%
6.8%
Henry Schein, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
6.10%
EBIT Growth (5y)
6.07%
EBIT to Interest (avg)
14.97
Debt to EBITDA (avg)
1.57
Net Debt to Equity (avg)
0.86
Sales to Capital Employed (avg)
2.09
Tax Ratio
24.67%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
15.35%
ROE (avg)
15.90%
Valuation key factors
Factor
Value
P/E Ratio
16
Industry P/E
Price to Book Value
2.55
EV to EBIT
14.97
EV to EBITDA
10.74
EV to Capital Employed
1.81
EV to Sales
0.90
PEG Ratio
0.47
Dividend Yield
NA
ROCE (Latest)
12.11%
ROE (Latest)
15.49%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
No Trend
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 107 Schemes (40.01%)
Foreign Institutions
Held by 276 Foreign Institutions (18.65%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
Dec'25
Sep'25
Change(%)
Net Sales
3,437.00
3,339.00
2.94%
Operating Profit (PBDIT) excl Other Income
290.00
286.00
1.40%
Interest
39.00
38.00
2.63%
Exceptional Items
-45.00
-42.00
-7.14%
Consolidate Net Profit
103.00
109.00
-5.50%
Operating Profit Margin (Excl OI)
60.50%
61.70%
-0.12%
USD in Million.
Net Sales
QoQ Growth in quarter ended Dec 2025 is 2.94% vs 3.06% in Sep 2025
Consolidated Net Profit
QoQ Growth in quarter ended Dec 2025 is -5.50% vs 15.96% in Sep 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
13,184.00
12,673.00
4.03%
Operating Profit (PBDIT) excl Other Income
1,089.00
1,026.00
6.14%
Interest
150.00
131.00
14.50%
Exceptional Items
-125.00
-120.00
-4.17%
Consolidate Net Profit
419.00
398.00
5.28%
Operating Profit Margin (Excl OI)
59.00%
57.50%
0.15%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 4.03% vs 2.71% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 5.28% vs -8.72% in Dec 2024
About Henry Schein, Inc. 
Henry Schein, Inc.
Retailing
Henry Schein, Inc. is a provider of healthcare products and services primarily to office-based dental and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins. The technology and value-added services segment provides software, technology and other value-added services to healthcare practitioners. Its technology group offerings include practice management software systems for dental and medical practitioners. The Company provides its services to dental practitioners and laboratories, and physician practices, as well as government and institutional healthcare clinics.
Company Coordinates 
Company Details
135 Duryea Rd , MELVILLE NY : 11747
Registrar Details






